• BioNTech SE average return on tangible equity for 2023 was 17.85, a 78.78% decline from 2022.
• BioNTech SE average return on tangible equity for 2022 was 84.1, a 43.21% decline from 2021.
• BioNTech SE average return on tangible equity for 2021 was 148.09, a 466.56% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.